Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
22.94
+0.82 (3.71%)
Sep 30, 2026, 3:04 PM CST
SHE:300255 Market Cap
SHE:300255 has a market cap or net worth of 21.08 billion as of October 2, 2026. Its market cap has decreased by -48.26% in one year.
Market Cap
21.08B
Enterprise Value
23.66B
Revenue
859.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.94
ChartMarket Cap Chart
Since August 19, 2011, SHE:300255's market cap has increased from 3.35B to 21.08B, an increase of 529.59%. That is a compound annual growth rate of 12.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 21.08B | -63.06% |
| Dec 31, 2025 | 57.07B | 210.66% |
| Dec 31, 2024 | 18.37B | 53.65% |
| Dec 29, 2023 | 11.96B | 137.41% |
| Dec 30, 2022 | 5.04B | -32.60% |
| Dec 31, 2021 | 7.47B | 31.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tiantan Biological Products | 24.90B |
| Hualan Biological Engineering | 24.35B |
| Acrobiosystems | 23.58B |
| Evopoint Biosciences | 21.51B |
| Xiamen Amoytop Biotech | 21.02B |
| Sino Biological,Inc. | 19.34B |
| Yili Chuanning Biotechnology | 18.28B |
| HitGen | 17.91B |